{"id":"W2167127007","doi":"10.5489/cuaj.67","title":"Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; Pfizer (Canada); Hôpital Notre-Dame; CancerCare Manitoba; BC Cancer Agency","funders":"","keywords":"Sunitinib; Medicine; Discontinuation; Renal cell carcinoma; Neutropenia; Toxicity; Side effect (computer science); Internal medicine; Tyrosine-kinase inhibitor; Oncology; Cancer; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003601852,0.001388429,0.002065063,0.001773573,0.0009973467,0.001443322,0.002604362,0.005016676,0.004927895],"category_scores_gemma":[0.007839486,0.0004735186,0.002397592,0.001139778,0.0006328811,0.001814013,0.001199465,0.007315922,0.004686798],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001919925,"about_ca_system_score_gemma":0.004261338,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004904508,"about_ca_topic_score_gemma":0.01082005,"domain_scores_codex":[0.9967588,0.001151147,0.0007833103,0.0001440251,0.0009876486,0.0001751001],"domain_scores_gemma":[0.9935374,0.00144531,0.001025073,0.0001541788,0.003058099,0.0007799813],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001428944,0.0003392896,0.001738786,0.003274089,0.0001105221,0.001113859,0.0002085362,0.001275555,0.001586867,0.001577495,0.5066584,0.4819736],"study_design_scores_gemma":[0.0003219842,0.0002268892,0.005419625,0.01037186,0.0002645222,0.002304889,0.000293194,0.0008360683,0.0004771979,0.003175077,0.9762408,0.00006790902],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.004595312,0.3898018,0.02827387,0.4844898,0.01470864,0.002833432,0.001674888,0.001769917,0.07185231],"genre_scores_gemma":[0.02695279,0.5558265,0.1692319,0.1693494,0.01786893,0.004326292,0.004980222,0.0004739048,0.05099016],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.005016676,"threshold_uncertainty_score":0.01904863,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04242709008124793,"score_gpt":0.2796902975201788,"score_spread":0.2372632074389309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}